Nanoviricides Inc (NNVC)
0.9900 -0.0500 (-4.81%) 04/08/25 [NYSE Arca]
0.9800 x 700 0.9900 x 200
Realtime by (Cboe BZX)
0.9800 x 700 0.9900 x 200
Realtime 0.9041 -0.0859 (-) 06:53 ET
for Tue, Apr 8th, 2025
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -8,294 | -8,589 | -8,107 | -8,822 | -13,447 |
Depreciation Amortization | 759 | 748 | 723 | 723 | 721 |
Accounts payable and accrued liabilities | 706 | 118 | 41 | -711 | 111 |
Other Working Capital | 997 | 1,799 | 215 | -540 | 120 |
Other Operating Activity | -483 | 254 | 1,237 | 1,137 | 5,830 |
Operating Cash Flow | $-6,316 | $-5,670 | $-5,891 | $-8,214 | $-6,666 |
Cash Flows From Investing Activities | |||||
PPE Investments | -157 | -152 | -324 | -239 | -9 |
Investing Cash Flow | $-157 | $-152 | $-324 | $-239 | $-9 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,255 |
Common Stock Issued | 3,120 | N/A | N/A | 16,564 | 16,677 |
Other Financing Activity | 0 | -95 | -235 | -1,303 | -105 |
Financing Cash Flow | $3,120 | $-95 | $-235 | $15,261 | $17,828 |
Beginning Cash Position | 8,150 | 14,066 | 20,517 | 13,709 | 2,555 |
End Cash Position | 4,798 | 8,150 | 14,066 | 20,517 | 13,709 |
Net Cash Flow | $-3,352 | $-5,917 | $-6,450 | $6,808 | $11,153 |
Free Cash Flow | |||||
Operating Cash Flow | -6,316 | -5,670 | -5,891 | -8,214 | -6,666 |
Capital Expenditure | -157 | -152 | -324 | -239 | -9 |
Free Cash Flow | -6,472 | -5,822 | -6,216 | -8,453 | -6,674 |